An overview on the role of antibiotic therapy in the treatment of Coronavirus disease 2019 (COVID-19)

被引：0

作者：

Afshar, Zeinab Mohseni ^{[1
]}

Sayad, Babak ^{[1
]}

Janbakhsh, Alireza ^{[1
]}

Ebrahimpour, Soheil ^{[2
]}

Babazadeh, Arefeh ^{[2
]}

机构：

[1] Kermanshah Univ Med Sci, Imam Reza Hosp, Clin Res Dev Ctr, Kermanshah, Iran

[2] Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol, Iran

来源：

MINERVA RESPIRATORY MEDICINE | 2023年 / 62卷 / 02期

关键词：

COVID-19; Anti-bacterial agents; Therapeutics; SARS-CoV-2;

D O I：

10.23736/S2784-8477.21.01940-4

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The coronavirus disease 2019 (COVID-19) pandemic made daily news of deaths. According to several studies, a signifi-cant number of deaths due to COVID-19 resulted from secondary bacterial infections. Consequently, antimicrobials are important tools in helping to defend against mortality in patients with COVOD-19. It should be noted that, antimicrobial resistance (AMR) is now estimated to cause notable global deaths. Points to consider that proportion of COVID-19 cases that are prescribed antibiotics are unclear and may be associated with patient injury and AMR. Thus, the aim of the cur-rent review was to focus on the role of antibiotic therapy in the treating of COVID-19.

引用

页码：83 / 88

页数：6

共 48 条

[1] Coronavirus disease 2019 (COVID-19), MERS and SARS: Similarity and difference [J].

Afshar, Zeinab Mohseni ;

Ebrahimpour, Soheil ;

Javanian, Mostafa ;

Koppolu, Veerendra ;

Vasigala, Veneela Krishna Rekha ;

Hasanpour, Amir Hossein ;

Babazadeh, Arefeh .

JOURNAL OF ACUTE DISEASE, 2020, 9 (05) :194-199

[2]

Alhazzani W, 2020, INTENS CARE MED, V46, P854, DOI [10.1007/s00134-020-06022-5, 10.1097/CCM.0000000000004363]

[3] Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome [J].

Bardi, Tommaso ;

Pintado, Vicente ;

Gomez-Rojo, Maria ;

Escudero-Sanchez, Rosa ;

Azzam Lopez, Amal ;

Diez-Remesal, Yolanda ;

Martinez Castro, Nilda ;

Ruiz-Garbajosa, Patricia ;

Pestana, David .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (03) :495-502

[4] Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020) [J].

Bhimraj, Adarsh ;

Morgan, Rebecca L. ;

Shumaker, Amy Hirsch ;

Lavergne, Valery ;

Baden, Lindsey ;

Cheng, Vincent Chi-Chung ;

Edwards, Kathryn M. ;

Gandhi, Rajesh ;

Muller, William J. ;

O'Horo, John C. ;

Shoham, Shmuel ;

Murad, M. Hassan ;

Mustafa, Reem A. ;

Sultan, Shahnaz ;

Falck-Ytter, Yngve .

CLINICAL INFECTIOUS DISEASES, 2020, 78 (07) :e83-e102

[5]

Binder RA, 2020, J INFECT DIS

[6] Azithromycin for COVID-19: More Than Just an Antimicrobial? [J].

Bleyzac, Nathalie ;

Goutelle, Sylvain ;

Bourguignon, Laurent ;

Tod, Michel .

CLINICAL DRUG INVESTIGATION, 2020, 40 (08) :683-686

[7]

Buetti N, 2020, J INFECT, V81, P148

[8] Is teicoplanin a complementary treatment option for COVID-19? The question remains [J].

Ceccarelli, Giancarlo ;

Alessandri, Francesco ;

d'Ettorre, Gabriella ;

Borrazzo, Cristian ;

Spagnolello, Ornella ;

Oliva, Alessandra ;

Ruberto, Franco ;

Mastroianni, Claudio M. ;

Pugliese, Francesco ;

Venditti, Mario .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (02)

[9] PRO: The COVID-19 pandemic will result in increased antimicrobial resistance rates [J].

Clancy, Cornelius J. ;

Buehrle, Deanna J. ;

Nguyen, M. Hong .

JAC-ANTIMICROBIAL RESISTANCE, 2020, 2 (03)

[10] Coronavirus Disease 2019, Superinfections, and Antimicrobial Development: What Can We Expect? [J].

Clancy, Cornelius J. ;

Nguyen, M. Hong .

CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) :2736-2743

← 1 2 3 4 5 →